Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/76252
Campo DC Valoridioma
dc.contributor.authorMaynar Moliner, Manuelen_US
dc.contributor.authorZander, Ten_US
dc.contributor.authorQian, Zen_US
dc.contributor.authorRostagno, Ren_US
dc.contributor.authorLlorens, Ren_US
dc.contributor.authorZerolo, Ien_US
dc.contributor.authorKirsch, Den_US
dc.contributor.authorSorrells, Len_US
dc.contributor.authorCastaneda, WRen_US
dc.date.accessioned2020-12-02T15:14:06Z-
dc.date.available2020-12-02T15:14:06Z-
dc.date.issued2005en_US
dc.identifier.issn1526-6028en_US
dc.identifier.otherWoS-
dc.identifier.urihttp://hdl.handle.net/10553/76252-
dc.description.abstractPurpose: To report our initial experience with a bifurcated endoprosthesis in the management of aortoiliac occlusive disease.Methods: From May 2001 to February 2004, 112 patients were referred to our institution for the management of aortoiliac disease. Among these, 5 (6%) patients (3 men; mean age 57.8 years) with severe ischemia owing to TASC C or D iliac occlusions were selected for endovascular treatment with a bifurcated stent-graft. An Excluder stent-graft was placed after preliminary recanalization (thrombolysis and/or balloon dilation) the day before. The patients were followed clinically and ultrasonographically every 3 months during the first year and semiannually thereafter.Results: Technical success was achieved in all patients. Endovascular aortoiliac bifurcation reconstruction restored iliac artery flow immediately in all cases. There were no procedure-related complications. The mean ankle-brachial index (ABI) was significantly improved, from 0.66+/-0.04 before the procedure to 0.94+/-0.06 immediately after the procedure (p<0.01). The aortoiliac reconstructions remained patent during the mean 17-month follow-up (range 3-36), and the ABIs were stable. There was no mortality or amputation required in this series.Conclusions: Endovascular placement of a bifurcated stent-graft appears to be technically feasible, effective, and safe in the management of aortoiliac occlusive disease.en_US
dc.languageengen_US
dc.relation.ispartofJournal of Endovascular Therapyen_US
dc.sourceJournal Of Endovascular Therapy [ISSN 1526-6028], v. 12 (1), p. 22-27, (Febrero 2005)en_US
dc.subject32 Ciencias médicasen_US
dc.subject320704 Patología cardiovascularen_US
dc.subject.otherPercutaneous Transluminal Angioplastyen_US
dc.subject.otherAortic Bifurcationen_US
dc.subject.otherKissing Stentsen_US
dc.subject.otherBypassen_US
dc.subject.otherArteryen_US
dc.subject.otherReconstructionen_US
dc.subject.otherGraften_US
dc.subject.otherAortoiliac Segmenten_US
dc.subject.otherOcclusive Diseaseen_US
dc.subject.otherThrombolysisen_US
dc.subject.otherEndovascular Repairen_US
dc.subject.otherStent-Graften_US
dc.titleBifurcated endoprosthesis for treatment of aortoiliac occlusive lesionsen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1583/04-1370R.1en_US
dc.identifier.scopus13644281865-
dc.identifier.isi000226954100004-
dc.contributor.authorscopusid7005962555-
dc.contributor.authorscopusid24537953400-
dc.contributor.authorscopusid57195594774-
dc.contributor.authorscopusid6603053476-
dc.contributor.authorscopusid7006542164-
dc.contributor.authorscopusid16641392900-
dc.contributor.authorscopusid7005339268-
dc.contributor.authorscopusid54382432000-
dc.contributor.authorscopusid7101832612-
dc.identifier.eissn1545-1550-
dc.description.lastpage27en_US
dc.identifier.issue1-
dc.description.firstpage22en_US
dc.relation.volume12en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.contributor.daisngid23221678-
dc.contributor.daisngid94228-
dc.contributor.daisngid20278976-
dc.contributor.daisngid4778533-
dc.contributor.daisngid28135379-
dc.contributor.daisngid3875761-
dc.contributor.daisngid3595344-
dc.contributor.daisngid4967106-
dc.contributor.daisngid1827169-
dc.description.numberofpages6en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Maynar, M-
dc.contributor.wosstandardWOS:Zander, T-
dc.contributor.wosstandardWOS:Qian, Z-
dc.contributor.wosstandardWOS:Rostagno, R-
dc.contributor.wosstandardWOS:Llorens, R-
dc.contributor.wosstandardWOS:Zerolo, I-
dc.contributor.wosstandardWOS:Kirsch, D-
dc.contributor.wosstandardWOS:Sorrells, L-
dc.contributor.wosstandardWOS:Castaneda, WR-
dc.date.coverdateFebrero 2005en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.jcr1,805
dc.description.jcrqQ2
dc.description.scieSCIE
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Tecnología Médica y Audiovisual-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.orcid0000-0001-9154-0712-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameMaynar Moliner,Manuel-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

31
actualizado el 24-mar-2024

Citas de WEB OF SCIENCETM
Citations

26
actualizado el 25-feb-2024

Visitas

106
actualizado el 23-ene-2024

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.